title: Caffeic acid phenethyl ester suppresses melanoma tumor growth by inhibiting PI3K/AKT/XIAP pathway.
abstract: Melanoma is highly metastatic and resistant to chemotherapeutic drugs. Our previous studies have demonstrated that caffeic acid phenethyl ester (CAPE) suppresses the growth of melanoma cells and induces reactive oxygen species generation. However, the exact mechanism of the growth suppressive effects of CAPE was not clear. Here, we determined the potential mechanism of CAPE against melanoma in vivo and in vitro. Administration of 10 mg/kg/day CAPE substantially suppressed the growth of B16F0 tumor xenografts in C57BL/6 mice. Tumors from CAPE-treated mice showed reduced phosphorylation of phosphoinositide 3-kinase, AKT, mammalian target of rapamycin and protein level of X-linked inhibitor of apoptosis protein (XIAP) and enhanced the cleavage of caspase-3 and poly (ADP ribose) polymerase. In order to confirm the in vivo observations, melanoma cells were treated with CAPE. CAPE treatment suppressed the activating phosphorylation of phosphoinositide 3-kinase at Tyr 458, phosphoinositide-dependent kinase-1 at Ser 241, mammalian target of rapamycin at Ser 2448 and AKT at Ser 473 in B16F0 and SK-MEL-28 cells in a concentration and time-dependent study. Furthermore, the expression of XIAP, survivin and BCL-2 was downregulated by CAPE treatment in both cell lines. Significant apoptosis was observed by CAPE treatment as indicated by cleavage of caspase-3 and poly (ADP ribose) polymerase. AKT kinase activity was inhibited by CAPE in a concentration-dependent manner. CAPE treatment increased the nuclear translocation of XIAP, indicating increased apoptosis in melanoma cells. To confirm the involvement of reactive oxygen species in the inhibition of AKT/XIAP pathway, cells were treated with antioxidant N-acetyl-cysteine (NAC) prior to CAPE treatment. Our results indicate that NAC blocked CAPE-mediated AKT/XIAP inhibition and protected the cells from apoptosis. Because AKT regulates XIAP, their interaction was examined by immunoprecipitation studies. Our results show that CAPE treatment decreased the interaction of AKT with XIAP. To establish the involvement of AKT in the apoptosis-inducing effects of CAPE, cells were transfected with AKT. Our results revealed that AKT overexpression attenuated the decrease in XIAP and significantly blocked CAPE-mediated apoptosis. Similarly, overexpression of XIAP further decreased CAPE-induced apoptosis. Taken together, our results suggest that CAPE suppresses phosphoinositide 3-kinase/AKT/XIAP pathway leading to apoptosis in melanoma tumor cells in vitro and in vivo.
authors: Department of Biomedical Sciences.
authors: Kartick C
authors: KC
authors: Pramanik
authors: Shashi K
authors: SK
authors: Kudugunti
authors: Neel M
authors: NM
authors: Fofaria
authors: Majid Y
authors: MY
authors: Moridani
authors: Sanjay K
authors: SK
authors: Srivastava
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002109:Caffeic Acids / Q000008:administration & dosage; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D064593:Heterografts; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D051058:Oncogene Protein v-akt / Q000037:antagonists & inhibitors / Q000378:metabolism*; D010626:Phenylethyl Alcohol / Q000008:administration & dosage / Q000031:analogs & derivatives; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D010766:Phosphorylation / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D051636:X-Linked Inhibitor of Apoptosis Protein / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D002109:Caffeic Acids; D051058:Oncogene Protein v-akt; D010626:Phenylethyl Alcohol; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D051636:X-Linked Inhibitor of Apoptosis Protein; C496866:XIAP protein, human; C055494:caffeic acid phenethyl ester
references: Cancer Detect Prev. 1995;19(3):292-8
references: 7750119
references: PLoS One. 2012;7(2):e31286
references: 22347457
references: Aviat Space Environ Med. 2008 Sep;79(9):919-21
references: 18785363
references: J Neurochem. 2008 Aug;106(3):1357-70
references: 18485100
references: Cancer Res. 1993 Mar 15;53(6):1255-61
references: 7680281
references: N Engl J Med. 1999 Sep 2;341(10):766-7
references: 10475803
references: Cancer Res. 1993 Oct 1;53(19):4528-33
references: 7691399
references: Clin Exp Immunol. 2010 May;160(2):223-32
references: 20059479
references: Leukemia. 2003 Nov;17(11):2081-9
references: 12970762
references: Br J Cancer. 2003 Dec 1;89(11):2110-5
references: 14647146
references: Invest New Drugs. 2011 Feb;29(1):52-62
references: 19844662
references: BJU Int. 2004 Aug;94(3):402-6
references: 15291876
references: Toxicology. 2005 Sep 15;213(1-2):81-96
references: 16085347
references: J Biol Chem. 2004 Feb 13;279(7):5405-12
references: 14645242
references: J Biol Chem. 2004 Feb 13;279(7):6017-26
references: 14625298
references: J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S124-32
references: 22018061
references: Carcinogenesis. 1996 Apr;17(4):761-5
references: 8625488
references: BMJ. 2008 Nov 20;337:a2249
references: 19022841
references: PLoS One. 2011 Mar 30;6(3):e18257
references: 21479172
references: Mol Carcinog. 1991;4(3):231-42
references: 1712205
references: Antioxid Redox Signal. 2012 Nov 15;17(10):1417-32
references: 22530568
references: Phytother Res. 2009 Feb;23(2):226-30
references: 18726924
references: J Natl Cancer Inst. 2009 Feb 4;101(3):176-93
references: 19176463
references: Leuk Lymphoma. 2004 Jul;45(7):1429-36
references: 15359644
references: Cancer Prev Res (Phila). 2012 May;5(5):788-97
references: 22562408
references: Cancer Lett. 2006 Mar 28;234(2):199-208
references: 15885897
references: J Biol Chem. 2000 Oct 13;275(41):31733-8
references: 10930419
references: Clin Cancer Res. 2011 Apr 1;17(7):1784-95
references: 21350002
references: World J Gastroenterol. 2006 Aug 21;12(31):4981-5
references: 16937493
references: EMBO J. 1998 Apr 15;17(8):2215-23
references: 9545235
references: J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S6-16
references: 22018069
references: J Agric Food Chem. 2001 Nov;49(11):5615-9
references: 11714368
references: PLoS One. 2011;6(5):e20151
references: 21647434
references: Chem Biol Interact. 2010 Oct 6;188(1):1-14
references: 20685355
references: Int J Biochem Cell Biol. 2008;40(11):2572-82
references: 18571461
references: Experientia. 1988 Mar 15;44(3):230-2
references: 2450776
references: Cancer Res. 2000 Oct 15;60(20):5659-66
references: 11059757
references: Nature. 1997 Jul 17;388(6639):300-4
references: 9230442